ALZN — ALZAMEND NEURO INC
As of Q2 2026, 3 SEC-registered investment managers reported holding ALZN (ALZAMEND NEURO INC) in their latest 13F filings, with a combined reported value of $34.99K across 29.16K shares. That is -60.5% by share count (-44.69K shares) versus the previous quarter, while reported value moved -55.3%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 trimmed, 2 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ALZN is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Vanguard Group history | Q4 2025 | 21.62K | $39.35K | 0.00% | Hold |
| Citadel Advisors history | Q4 2024 | 30.64K | $35.54K | 0.00% | New |
| Geode Capital Management history | Q2 2026 | 26.37K | $31.64K | 0.00% | Reduce |
| Morgan Stanley history | Q1 2026 | 18.00K | $19.08K | 0.00% | Hold |
| Renaissance Technologies history | Q4 2024 | 15.00K | $17.40K | 0.00% | New |
| Citigroup Inc history | Q1 2026 | 5.23K | $5.54K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 2.35K | $2.82K | 0.00% | Reduce |
| Wells Fargo & Co history | Q3 2024 | 1.00K | $1.69K | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 437 | $524 | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 43 | $78 | 0.00% | Add |
New Positions (Q2 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- Morgan Stanley sold 18.00K sh · $19.08K
- Citigroup Inc sold 5.23K sh · $5.54K
Fund Position History — shares by quarter (top 10 funds)
| Fund | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Geode Capital Management | 52.40K | 52.40K | 52.40K | — | 33.54K | 39.15K | — | 20.58K | 27.51K | 45.68K | 26.37K |
| UBS Group AG | 1.91K | — | 5.13K | — | 820 | — | 902 | 2.08K | 24.57K | 4.50K | 2.35K |
| BlackRock Inc | — | — | — | 3.97K | 3.97K | 3.97K | 441 | 437 | 437 | 437 | 437 |
| Morgan Stanley | 33 | 33 | 33 | 3 | 3 | 3 | — | — | 18.00K | 18.00K | — |
| Bank of America Corp | 47 | — | 95 | 105 | 136 | 146 | 19 | 37 | 43 | — | — |
| Citigroup Inc | — | — | — | — | 544 | — | — | 1 | — | 5.23K | — |
| Vanguard Group | 78.55K | 78.55K | 78.55K | — | — | — | — | 21.62K | 21.62K | — | — |
| Citadel Advisors | — | — | — | — | 30.64K | — | — | — | — | — | — |
| Renaissance Technologies | 10.19K | 13.79K | 19.69K | — | 15.00K | — | — | — | — | — | — |
| Wells Fargo & Co | 35 | 39 | — | 1.00K | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details